Chicago-based healthcare investor Shore Capital Partners has held a $112.5m final close for its latest fund.
The firm attracted pension funds, financial institutions, fund of funds and family offices to the vehicle, which it said was substantially oversubscribed.
Shore plans to stick with its existing strategy of investing in control buyouts of microcap healthcare businesses with EBITDA of between $1m and $5m.
It targets equity commitments of between $10m and $15m per platform.
Shore founder and managing partner Justin Ishbia said, “We are very pleased with the reception Shore Capital Partners Fund I received from such a highly respected group of institutional investors.
“This is an important milestone for Shore and we believe the interest shown by investors validates our strategy to invest in microcap healthcare companies that can benefit from our operational and financial support.”
Shore’s principals have been investing together since 2009, completing 14 acquisitions across five platforms.
Prior to founding Shore, Ishbia worked at Valor Equity Partners and was previously an attorney in the private equity group at Kirkland Ellis.
Copyright © 2014 AltAssets